SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-18-003893
Filing Date
2018-04-02
Accepted
2018-04-02 16:50:54
Documents
54
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2017_immudyneinc.htm 10-K 853728
2 CERTIFICATION f10k2017ex31-1_immudyne.htm EX-31.1 13568
3 CERTIFICATION f10k2017ex31-2_immudyne.htm EX-31.2 12966
4 CERTIFICATION f10k2017ex32-1_immudyne.htm EX-32.1 6654
5 CERTIFICATION f10k2017ex32-2_immudyne.htm EX-32.2 6714
  Complete submission text file 0001213900-18-003893.txt   5694676

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE immd-20171231.xsd EX-101.SCH 46403
7 XBRL CALCULATION FILE immd-20171231_cal.xml EX-101.CAL 27512
8 XBRL LABEL FILE immd-20171231_lab.xml EX-101.LAB 520527
9 XBRL DEFINITION FILE immd-20171231_def.xml EX-101.DEF 270391
10 XBRL PRESENTATION FILE immd-20171231_pre.xml EX-101.PRE 373782
11 XBRL INSTANCE FILE immd-20171231.xml EX-101.INS 1067029
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55857 | Film No.: 18729678
SIC: 2833 Medicinal Chemicals & Botanical Products